CCS/Pfizer ATTR-CM Research Fellowship Award
The Canadian Cardiovascular Society (CCS) and Pfizer have collaboratively created a research fellowship award entitled “CCS-Pfizer ATTR-CM Research Fellowship Award.”
This is a salary award where the purpose is to foster the growth of peer-reviewed Canadian research in the area of Transthyretin Amyloid Cardiomyopathy (ATTR-CM), with a focus on excellence and support for early career Canadian researchers familiar with diagnosing and treating patients with ATTR-CM who are looking to establish an independent research career.
Deadline: Wednesday, April 7, 2021 at 12:00 p.m. EST
Click here to apply today!
- Be a CCS Member. For more information about CCS Membership, visit the CCS website: http://www.ccs.ca/en/membership
- Have completed an MD degree (or equivalent) and have obtained a fellowship from the Royal College of Physicians & Surgeons of Canada (or equivalent from a foreign country) or from the Canadian College of Family Physicians; or have completed a PharmD; or have completed a PhD (post-doc).
- Have proof of a letter of acceptance to a faculty or clinical position at a Canadian institution.
- Applicants must be Canadian Citizens.
- Funded research must be conducted at a site in Canada associated with Canadian research institutions that are eligible to hold research funding (https://cihr-irsc.gc.ca/e/36374.html).
- Applications for this award must be supported by the university or institution at which the applicant will conduct the proposed research program.
A single salary award of $60,000 will be awarded to one individual based on an independent peer review process. Funding begins the summer of 2021 for 12 months.
Applicants are asked to submit a proposal, including the following:
- Research Program Outline. Provide an outline of the proposed research program (max 3 pages/1500 words), including an executive summary of the proposed program of research. Ensure the outline describes the contribution this program of research has the potential to contribute to the field. The applicant should clearly demonstrate the potential to become an independent investigator.
- Operating Grants. List any operating grant(s) that have been secured to support the proposed research program.
- Institution. Indicate the institution that will administer the award funds.
- Institutional Statement. Applications for this award must be supported by the university or institution at which the applicant will conduct the proposed research program. Provide a statement completed by the Dean and Department Head (or institutional equivalents) demonstrating commitment of the university or institution to provide the applicant appropriate academic rank, time allocated to the proposed research program, and to provide adequate space and facilities for the investigator’s research, as well as a commitment to developing the applicant’s research, technical and professional skills and networks over the training period by providing career planning, skills development and networking opportunities to prepare the trainee for an impactful career.
- In 280 characters or less, clearly explain the proposed research program to a general audience (at a level no greater than grade 8).
- (for use in promoting and recognizing the award and awardee).
- Appendices related to the research program (optional). Follow general formatting guidelines for all appendices.
- CVs of the Applicant Fellow and at least one (1) Primary Supervisor. CVs must be no longer than two (2) pages each and should include only peer-reviewed publications and abstracts from the last five (5) years. Do not include presentations, conferences, lectures or non-peer-reviewed publications. CVs should be uploaded in one PDF file.
The Peer Review Process
All applications will be pre-screened for eligibility. Applications that are late, incomplete and/or do not meet the basic eligibility criteria will be not be considered for review. Peer review of all eligible applications will be conducted by a scientific review committee comprised of CCS members. All eligible proposals will be reviewed by at least two members of the peer review committee. All applicants will receive feedback from reviewers. All applicants will receive notification of funding/non-funding and awards will be announced by June 30.
If you have any questions or require support preparing and submitting your application, please email firstname.lastname@example.org.
The Canadian Cardiovascular Society and Pfizer Canada are proud to support the CCS-Pfizer ATTR-CM Research Fellowship Award. With this award, we hope to support early career Canadian researchers familiar with diagnosing and treating patients with ATTR-CM who are looking to establish an independent research career.